NicOx SA (COX.PA) Launches Adenoplus® And Xailin™ Dry Eye Product Range In Europe
3/17/2014 9:07:16 AM
SOPHIA ANTIPOLIS, France, March 17, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX) today announced the European launch of Xailin(TM), a new range of tear lubricants (medical devices) for relief of dry eye symptoms, and of AdenoPlus®, an in vitro diagnostic medical device (IVDMD) to help the differential diagnosis of acute conjunctivitis. Nicox is now promoting and selling the first Xailin(TM) products and AdenoPlus® through its own sales force in the UK, Italy, Spain and France. Commercial operations in Germany are expected to begin in the second quarter of 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by